Signaling pathways
-
A9078 Z-FY-CHOSummary: Z-FY-CHO is a potent and specific cathepsin L inhibitor. -
A9082 Taurocholic acid-d4Summary: Taurocholic acid-d4 is deuterium labeled Taurocholic acid. It intended for use as an internal standard for the quantification of TCA by GC- or LC-MS. -
A9083 L-Cysteine-¹³C3Summary: L-Cysteine-¹³C3 is the ¹³C-labeled L-Cysteine. It acts as a precursor for biologically active molecules such as hydrogen sulphide (H2S), glutathione and taurine. L-Cysteine suppresses ghrelin and reduces appetite in rodents and humans. -
BA2641 MC-VA-PABC-MMAESummary: MC-VA-PABC-MMAE is part of an antibody-coupled active molecule. - BA2642 MC-betaglucuronide-MMAE-1Summary: MC-betaglucuronide-MMAE-1 is part of.
- BA2643 DM21Summary: DM21 is a cleavable affix of an ADC active molecule and linker (ADClinker).
- BA2645 Mal-PEG4-VC-PAB-DMEA-PNU-159682Summary: Mal-PEG4-VC-PAB-DMEA-PNU-159682 is an active molecule-coupling consisting of the ADC connector Mal-PEG4-VC-PAB and the potent ADC cytotoxin DMEA-PNU-159682.
- BA2646 Amino-PEG4-Val-Cit-PAB-MMAESummary: Can be used to synthesize antibody-coupled reactive molecules (ADCs).
- BA2647 DBCO-PEG4-Val-Cit-PAB-MMAFSummary: DBCO-PEG4-Val-Cit-PAB-MMAF consists of degradable (cleavable) 4-unit PEG-containing (DBCO-PEG4-Val-Cit-PAB) and MMAF.
- BA2648 Mal-PEG8-Val-Cit-PAB-MMAESummary: Mal-PEG8-Val-Cit-PAB-MMAE is part of the antibody-coupled active molecule ADC.